Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 18

Trial Status

Completed8

Role Distribution

Principal Investigator8
PI Rate100%

Activity Timeline

Clinical Trials (8)

NCT00621101Phase 1Completed
Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects
Drug InteractionsHypercholesterolemiaImmunosuppression+1 more
Principalinvestigator
NCT00621699Phase 1Completed
Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy Subjects
Drug InteractionsHypercholesterolemiaImmunosuppression+1 more
Principalinvestigator
NCT02493283Phase 1Completed
Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administration
Linear IgA Bullous DermatosisMethemoglobinemia
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT00621101Phase 1PrincipalInvestigator

Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects

Drug InteractionsHypercholesterolemiaImmunosuppression+1 more
Completed
NCT00621699Phase 1PrincipalInvestigator

Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy Subjects

Drug InteractionsHypercholesterolemiaImmunosuppression+1 more
Completed
NCT00810303Phase 1PrincipalInvestigator

Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2

Drug InteractionsIntestinal Transporter ExpressionPharmacodynamics+1 more
Completed
NCT02493283Phase 1PrincipalInvestigator

Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administration

Linear IgA Bullous DermatosisMethemoglobinemia
Completed
NCT02494830Phase 1PrincipalInvestigator

Single Dose Administration of Ketamine 10, 20, 40 and 80 mg and 5 mg Solution for Infusion in 15 Healthy Subjects

Healthy
Completed
NCT02507167Phase 1PrincipalInvestigator

Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8

Gastrointestinal Hormones
Completed
NCT02509559Phase 1PrincipalInvestigator

Effects of Propranolol (vs. Placebo) on Information Processing During Presentation of Emotionally Arousing Pictures

Emotions
Completed
NCT02514941Phase 1PrincipalInvestigator

Bioavailability of Paracetamol, Amoxicillin and Talinolol Before, Immediately and One Year After Gastric Bypass Operation

Morbid Obesity
Completed

All 8 trials loaded